United Therapeutics To Review Positive TETON-2 Pivotal Study Data Of Nebulized Tyvaso In Idiopathic Pulmonary Fibrosis At ERS Congress Sept. 28, 2025; Study Met Primary And Most Secondary Endpoints
Author: Benzinga Newsdesk | September 19, 2025 06:03am